The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy-Reference-Cited by-同舟云学术

The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy

Published:2012 Issue:1 Volume:13 Page:59
ISSN:1465-9921
Container-title:Respiratory Research
language:en
Short-container-title:Respiratory Research

Author:

Buhl Roland,Kuna Piotr,Peters Matthew J,Andersson Tomas LG,Naya Ian P,Peterson Stefan,Rabe Klaus F

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Reference24 articles.

1. Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma

2. Respiratory medications and risk of asthma death

3. The Use of β-Agonists and the Risk of Death and near Death from Asthma

4. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma

5. Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Albuterol/Budesonide as Reliever Therapy to Reduce Asthma Exacerbations;The Journal of Allergy and Clinical Immunology: In Practice;2024-04

2. Patient response to the management during the acute presentation of cough variant Asthma: Retrospective cohort study;Saudi Journal of Biological Sciences;2023-12

3. Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy;The Journal of Allergy and Clinical Immunology: In Practice;2023-07

4. The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review;The Journal of Allergy and Clinical Immunology: In Practice;2023-03

5. A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid–Formoterol Inhalers in Asthma;American Journal of Respiratory and Critical Care Medicine;2023-02-15